Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation

Trends in Immunology

Volumn 34, Issue 6, 2013, Pages 243-250

  Roth, Susanne ^a   Ruland, Jürgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Host protection; Inflammatory disease; Innate immunity; Pattern recognition receptor signaling NF B

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CASPASE RECRUITMENT DOMAIN CONTAINING PROTEIN 9; DECTIN 1; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE C; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; HOMEOSTASIS; HOST RESISTANCE; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; DEAD-BOX RNA HELICASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; MULTIPROTEIN COMPLEXES; NOD SIGNALING ADAPTOR PROTEINS; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84878523947     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.02.006     Document Type: Review

References (61)

1. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
2. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
3. Kerrigan A.M., Brown G.D. Syk-coupled C-type lectins in immunity. Trends Immunol. 2011, 32:151-156.
4. Osorio F., Reis e Sousa C. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 2011, 34:651-664.
5. Sancho D., Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 2012, 30:491-529.
6. Hara H., Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol. 2009, 30:234-242.
7. Ruland J. CARD9 signaling in the innate immune response. Ann. N. Y. Acad. Sci. 2008, 1143:35-44.
8. Drewniak A.A., et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 2013, 10.1182/blood-2012-08-450551.
9. Glocker E.O., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 2009, 361:1727-1735.
10. Gross O., et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006, 442:651-656.
11. Saijo S., et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 2007, 8:39-46.
12. Saijo S., et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691.
13. Taylor P.R., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 2007, 8:31-38.
14. Wells C.A., et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 2008, 180:7404-7413.
15. Franke A., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
16. McGovern D.P., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 2010, 42:332-337.
17. Reveille J.D. Genetics of spondyloarthritis - beyond the MHC. Nat. Rev. Rheumatol. 2012, 8:296-304.
18. Rivas M.A., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 2011, 43:1066-1073.
19. Zhernakova A., et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet. 2008, 82:1202-1210.
20. Bertin J., et al. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J. Biol. Chem. 2000, 275:41082-41086.
21. Hsu Y.M., et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 2007, 8:198-205.
22. Mocsai A., et al. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat. Rev. Immunol. 2010, 10:387-402.
23. Thome M. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 2008, 8:495-500.
24. Staal J., et al. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J. 2011, 30:1742-1752.
25. Hailfinger S., et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14596-14601.
26. Rebeaud F., et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 2008, 9:272-281.
27. Coornaert B., et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 2008, 9:263-271.
28. Staal J., et al. Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase. Cell Res. 2011, 21:40-54.
29. Hara H., et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 2007, 8:619-629.
30. Ariizumi K., et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 2000, 275:20157-20167.
31. Brown G.D., Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001, 413:36-37.
32. Goodridge H.S., et al. Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. J. Immunol. 2009, 182:1146-1154.
33. LeibundGut-Landmann S., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
34. 2+ flux and cytokine production in dendritic cells. J. Biol. Chem. 2009, 284:7038-7046.
35. Gringhuis S.I., et al. Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog. 2011, 7:e1001259.
36. Strasser D., et al. Syk kinase-coupled C-type lectin receptors engage protein kinase C-delta to elicit Card9 adaptor-mediated innate immunity. Immunity 2012, 36:32-42.
37. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009, 459:433-436.
38. Gringhuis S.I., et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat. Immunol. 2012, 13:246-254.
39. Robinson M.J., et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 2009, 206:2037-2051.
40. Ishikawa E., et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 2009, 206:2879-2888.
41. Schoenen H., et al. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 2010, 184:2756-2760.
42. Yamasaki S., et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008, 9:1179-1188.
43. Werninghaus K., et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J. Exp. Med. 2009, 206:89-97.
44. Dorhoi A., et al. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 2010, 207:777-792.
45. Saleh M. The machinery of Nod-like receptors: refining the paths to immunity and cell death. Immunol. Rev. 2011, 243:235-246.
46. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
47. Poeck H., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 2010, 11:63-69.
48. Abdullah Z., et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J. 2012, 31:4153-4156.
49. Kolls J.K., Khader S.A. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 2010, 21:443-448.
50. Hernandez-Santos N., Gaffen S.L. Th17 cells in immunity to Candida albicans. Cell Host Microbe 2012, 11:425-435.
51. Puel A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
52. Drummond R.A., et al. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur. J. Immunol. 2011, 41:276-281.
53. Ferwerda B., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 2009, 361:1760-1767.
54. Cunha C., et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 2010, 116:5394-5402.
55. Plantinga T.S., et al. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2009, 49:724-732.
56. Wu W., et al. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat. Immunol. 2009, 10:1208-1214.
57. Van Limbergen J., et al. The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 2009, 10:89-116.
58. Cooke J., et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:2128-2137.
59. Janse M., et al. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology 2011, 53:1977-1985.
60. Evans D.M., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 2011, 43:761-767.
61. Pointon J.J., et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 2010, 11:490-496.